MedTrace Logo

Evaluation of a Physical Intervention for Persistent Post-Concussive Symptoms

NCT03357042 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-06-01

No results posted yet for this study

Summary

A concussion occurs when a person receives an impact to the head. The most common persistent symptoms that generate from a concussion are headaches, depression, lack of balance and dizziness. One recommendation to alleviate persistent symptoms of concussion is rest. Research findings indicate that the benefit of rest is inconclusive to help individuals suffering from a concussion return to activities of daily living. One treatment approach in reducing concussion symptoms is physical exercise therapy. Research findings, however, are limited to treatments being administered before the symptoms are considered persistent. Based on this rationale, the aim of this study is to examine the effect of a physical therapy intervention in minimizing persistent symptoms of concussion using measures of cognition and brain function, mental and physical health, and driving performance. If successful, this physical therapy intervention may help treat persistent concussion symptoms, improving the quality of life and ability for individuals to function normally in their daily lives, and resulting in savings to the healthcare system

Conditions

  • Persistent Post-Concussive Syndrome

Interventions

OTHER

Aerobic exercise and balance retraining

Aerobic and balance exercises that gradually progress in intensity over the course of 8 weeks.

OTHER

Standard of care

Normal concussion treatment; physical and cognitive rest

Sponsors & Collaborators

  • Northern Ontario School of Medicine

    collaborator OTHER

  • Lakehead University

    lead OTHER

Principal Investigators

  • Sheryl Wark, M.D. · Northern Ontario School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-08
Primary Completion
2019-12-31
Completion
2020-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03357042 on ClinicalTrials.gov